Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ang

Showing results (311-320 of 345) with videos related to

Pageof 35
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 1, 1982
Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTCK K Ang, E van der Schueren, G Notter, et al.
The Lancet. Oncology|February 28, 2009
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient dataStefan Michiels, Aurélie Le Maître, Marc Buyse, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinomaS P Choo, B Chowbay, Q S Ng, et al.
Cancer|April 1, 1997
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort studyF B Geara, B S Glisson, G Sanguineti, et al.
Nature Communications|January 5, 2017
Pushing the limits of CMOS optical parametric amplifiers with USRN:Si<sub>7</sub>N<sub>3</sub> above the two-photon absorption edgeK J A Ooi, D K T Ng, T Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Unilateral radiotherapy for the treatment of tonsil cancerGregory M Chronowski, Adam S Garden, William H Morrison, et al.
Investigative Ophthalmology & Visual Science|August 1, 2009
Cultivated human conjunctival epithelial transplantation for total limbal stem cell deficiencyLeonard P K Ang, Hidetoshi Tanioka, Satoshi Kawasaki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?Jennifer C O'Daniel, Adam S Garden, David L Schwartz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyR Granata, R Miceli, E Orlandi, et al.
Pageof 35

Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
International Journal of Radiation Oncology, Biology, Physics|October 1, 1982
Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTCK K Ang, E van der Schueren, G Notter, et al.
The Lancet. Oncology|February 28, 2009
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient dataStefan Michiels, Aurélie Le Maître, Marc Buyse, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinomaS P Choo, B Chowbay, Q S Ng, et al.
Cancer|April 1, 1997
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort studyF B Geara, B S Glisson, G Sanguineti, et al.
Nature Communications|January 5, 2017
Pushing the limits of CMOS optical parametric amplifiers with USRN:Si<sub>7</sub>N<sub>3</sub> above the two-photon absorption edgeK J A Ooi, D K T Ng, T Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Unilateral radiotherapy for the treatment of tonsil cancerGregory M Chronowski, Adam S Garden, William H Morrison, et al.
Investigative Ophthalmology & Visual Science|August 1, 2009
Cultivated human conjunctival epithelial transplantation for total limbal stem cell deficiencyLeonard P K Ang, Hidetoshi Tanioka, Satoshi Kawasaki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?Jennifer C O'Daniel, Adam S Garden, David L Schwartz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyR Granata, R Miceli, E Orlandi, et al.
Pageof 35